Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by carduon Jan 08, 2011 7:57pm

282 Views

Post# 17944346

OT

Any of you parents or grandparents who have kids in college or university and are faced with exorbitant charges for textbooks I offer a modicum of relief. My granddaughter, who is attending college, was faced with a bill of $200 for an 8th edition physics textbook. I contacted Amazon and got the book sent for $70 which included all taxes and shipping and handling charges and the book is brand new.

In today's economy every little counts.

Bullboard Posts

Rising miner increases graphite price, restarts Québec mill